UACA anticorps
Aperçu rapide pour UACA anticorps (ABIN3024023)
Antigène
Voir toutes UACA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Purification
- Protein G affinity chromatography
-
Immunogène
- Nuclei of myeloid leukemia biopsy cells were used as the immunogen for the UACA antibody.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Optimal dilution of the UACA antibody should be determined by the researcher.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Western blot: 0.5-1 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the UACA antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- UACA (Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA))
-
Autre désignation
- UACA
-
Sujet
- UACA (Uveal Autoantigen with Coiled-coil domains and Ankyrin repeats) is a 1,416 amino acid nuclear membrane protein. It was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves' disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
-
Pathways
- Positive Regulation of Endopeptidase Activity
Antigène
-